Clinical Efficacy of Topical Terbinafine Versus Topical Luliconazole in Treatment of Tinea Corporis/Tinea Cruris Patients
C. P. Vidhya Lakshmi, Girish M. Bengalorkar, V. Shiva Kumar
Journal of Pharmaceutical Research International · pp. 1001–1014 · Published 24 Aug 2013
10.9734/BJPR/2013/4348Abstract
Aims: Tinea corporis & cruris of skin respond well to topical antifungal therapy, but there is a need to apply cream 2- 3 times daily for up to four weeks will impair compliance & lead to treatment failure. Luliconazole is one of those drugs offering good efficacy & tolerability with a short duration of treatment. Terbinafine, an allylamine antifungal agent, acts by selective inhibition of fungal squalene epoxidase. Luliconazole, an imidazole antifungal agent is considered to be more effective in inhibition of ergosterol biosynthesis and its reservoir property in stratum corneum is greater than that of terbinafine. As there are lack of studies between terbinafine & luliconazole, the present study was undertaken to compare the clinical efficacy in tinea corporis/tinea cruris patients. Study Design: Prospective parallel study. Place and Duration of Study: Study was conducted on 60 patients presenting to the Dermatology out-patient department of RL Jalapa Hospital, Kolar, from 1st December 30th April 2012. Methodology: Patients alternatively assigned to either terbinafine or luliconazole & advised to apply test drugs topically for 14 days. Clinical symptoms & signs were assessed using 4-point (pruritus, erythema, scaling) scale & 10% KOH mount at base line, end of treatment visit (15th day) & later 30th day. The data was analysed based on age, gender distribution, duration of lesion, clinical score & KOH mount. Results: Of the 60 patients recruited, all came for 1st follow up (14th day) & 51 patients for 2nd follow-up (30th day). Mean age of the patients was 33.80± 9.58 years in terbinafine & 33.90 ± 9.58 years luliconazole group. Majority of patients were in 12- 40 years aged in both group. Sixty patients and 51 patients were negative for KOH mount preparation on 15th & 30th day respectively. At the end of first follow-up, the clinical score was reduced from 3 to zero (P=0.0001) in both the treatment groups. Mycological cure was 100% in both the drug groups. There was no relapse in 51 patients who came for 2nd follow-up. Four in terbinafine and 5 in luliconazole group were lost to follow up. Conclusion: Only mild forms of tinea infections were included as compared to other studies where moderate to severe (pustules, incrustations, vesiculation). Hence the onset of illness, treatment duration and severity of illness were favorable in this study for two weeks. In both the treatment arms, clinical & mycological cure was comparable, hence once a day application for two weeks of terbinafine & luliconazole were equally effective for treatment of tinea corporis/cruris infection.
References (14)
- 1 Ecology and epidemiology of dermatophyte infections [DOI]
- 2 In vitroantifungal activities of luliconazole, a new topical imidazole [DOI]
- 3 In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent [DOI]
- 4 Superficial Fungal Infections Seen at the National Skin Centre, Singapore [DOI]
- 5 In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses [DOI]
- 6 Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study [DOI]
- 7 A Study on Superficial Fungal Infection from West Bengal: A Brief Report [DOI]
- 8 Treatment of tinea cruris with topical terbinafine [DOI]
- 9 Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris [DOI]
- 10 Once daily treatment with terbinafine 1% cream (LamisilR) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study [DOI]
- 11 Novel, single‐dose, topical treatment of tinea pedis using terbinafine: results of a dose‐finding clinical trial [DOI]
- 12 Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
- 13 FUNGAL INFECTION AS A CAUSE OF SKIN DISEASE IN WESTERN AUSTRALIA [DOI]
- 14 KOH mount for superficial fungal infections using cellophane tape: comparison with standard technique.
Cited by 15
Ankita Sawant, Nikhil Nikam, Pratiksha Tupe · International Journal of Advanced Research in Science, Communication and Technology · 2025
T. Sowmya, N. .. Kumar, S. Syed · World Journal of Biology Pharmacy and Health Sciences · 2024
Amber Vyas, Vishal Jain · International Journal of Technology · 2023
N. Kaur, Aarti Bains, R. Kaushik · Nutrients · 2021
Philippa J. May, Steven Y. C. Tong, A. Steer · Tropical medicine & international health · 2019
M. Fahim · 2018
D. Chatterjee, S. Ghosh, Sukanta Sen · Indian Journal of Pharmacology · 2016
D. Khanna, Subhash Bharti · Core Evidence · 2014
S. Verma, Saumya Panda, P. Nenoff · Indian Journal of Dermatology, Venereology and Leprology · 2021
Hari Kumar, A. R. Kumar, G. Anubhav · International Journal of Current Research and Review · 2021
Related research
- Prevalence of Dermatophytosis in Badaun, Uttar Pradesh, India — shares topic coverage
Article metrics
Real usage data collected on this platform.
11
Page views
0
PDF downloads
1
Outbound clicks
15
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.